Diabetic nephropathy : A Review

Navneet Kaur1, Latika Khosla2
1Department of Biotechnology, CT Institute of Pharmaceutical Sciences, Shahpur, Jalandhar-144001, Punjab.
2Department of Biotechnology, Kanya Maha Vidyalaya, Jalandhar-144004, Punjab

Diabetic nephropathy (DN) is defined as a progressive pathological condition of the kidney caused by angiopathy of glomerular capillaries. The angiopathy of these capillaries is characterized by a progressive loss of glomerular filtration surface areas and capillary volume. DN is the leading cause of end-stage renal disease, and a major contributing factor to morbidity and mortality of diabetic patients throughout the world.


Abhineet Shrivastava
1, Soumyanath Mishra2
1 Manager, Overseas business development department Coating and Engineering material division, Mitsui Chemicals Inc
2 Head, Packaging development, Mankind Pharmaceutical Ltd.

Environment pollution : Case of China and what India can learn from it

As global economy is growing, the problem of environment pollution is also increasing rapidly and now it cannot be overlooked anymore. Indeed it is imperative for countries globally to restore their ecological environment. In 2016 the World health Organization (WHO) released a report on atmospheric pollution. In this report it is said that 92% of the world’s population are exposed to atmospheric pollution of hazardous level. Data from International Energy Agency (IEA) also shows that in 2016 , 6.5 million died as a result of atmospheric pollution. One of the cause for atmospheric pollution is the use of organic solvents during industrial production. Therefore, a matter that urgently needs to be addressed is the reduction of use of organic solvent in order to reduce VOC emission.


As per analysis of United States Government Accountability Office (GAO), preliminary analysis of Food and Drug Administration (FDA) data shows that from fiscal year 2012 through 2016, the number of foreign drug manufacturing establishment inspections increased. From fiscal year 2016 through 2018, both foreign and domestic inspections decreased by about 10 percent and 13 percent, respectively.

Highest Pharmaceutical mergers and acquisitions of 2019

Mergers and acquisitions (M&As) are perpetual part of big pharmaceutical industries and we have witnessed many such mergers and acquisitions. The financial crisis and resulting uncertainty in the global economies has made it difficult for companies to predict future performance of their own or their target’s or to forecast synergies and other transaction benefits with the same level of confidence seen in the past. As a result, acquirors and targets have developed transaction structures that are aimed at bridging gaps in their respective assessments of valuation and risk.

This article is focusing on top Pharmaceutical M&As of the year 2019.

Metabolic Syndrome : A Review

Navneet Kaur1, Narinder Singh2, Daisy Sharma2.
1Department of Biotechnology, CT Institute of Pharmaceutical Sciences, Shahpur, Jalandhar-144001, Punjab.
2Department of Pharmaceutics, CT Institute of Pharmaceutical Sciences, Shahpur, Jalandhar-144001, Punjab

Metabolic syndrome is defined by a group of interconnected physiological and a few biochemical or clinical disorder which directly affect the high risk rate of diseases such as cardiovascular disease (hypertension) also causing type 2 diabetes mellitus and mortality. The metabolic syndrome is higher prevalence in Western counterparts other than the urban population of some emerging countries. In the review Definition of syndrome, pathophysiology, and some criteria would be proposed for the clinical diagnosis and underlying management approaches for metabolic syndrome.

Can India ever demolish misuse of antibiotics?

  • Posted on: 31 December 2019
  • By: admin

Antibiotic resistance (AMR) is rising to dangerously high levels in all parts of the world. New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases. Antimicrobial Resistance is an increasingly serious threat to public health. The spread of multi-drug resistant bacteria and the lack of new antibiotics to treat infections caused by these organisms pose a rapidly increasing threat to human health which urgently needs to be tackled.


Orphan drugs are medicinal products intended for diagnosis, prevention or treatment of life-threatening or very serious diseases or disorders that are rare. In USA, the Orphan Drug Act was passed in 1983 to give drug companies incentives to develop treatments for rare diseases. India does not have laws on orphan drugs though CDSCO defined orphan drugs as those intended to treat a condition which affects fewer than 200,000 people.

How to register as pharmacist in USA from any foreign countries including India?

United States half pharmacies are located within drug stores, grocery stores, hospitals, department stores, medical clinics, surgery clinics, universities, nursing homes, prisons, and other facilities. The remaining pharmacies are considered to be independent or privately owned. In USA, average salary of pharmacists is 99000-140000 USD per annum. It can be varied depending on many factors.